<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#4e67ad"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007682"/>
	<fontspec id="font2" size="9" family="Courier" color="#007682"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#000000"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font13" size="10" family="GillSans" color="#000000"/>
	<fontspec id="font14" size="7" family="GillSans" color="#000000"/>
	<fontspec id="font15" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font16" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font17" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="67" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title">Bio Med Central<a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="756" left="503" width="51" height="10" font="font4" id="p1_t2" reading_order_no="60" segment_no="21" tag_type="text">Page 1 of 12<a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t3" reading_order_no="61" segment_no="22" tag_type="text">(page number not for citation purposes)<a href="http://www.biomedcentral.com/">Central</a></text>
<text top="35" left="55" width="163" height="23" font="font6" id="p1_t4" reading_order_no="0" segment_no="0" tag_type="title">Cell Division</text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t5" reading_order_no="2" segment_no="2" tag_type="title">Open Access<i>(page number not for citation purposes)</i></text>
<text top="87" left="55" width="40" height="13" font="font8" id="p1_t6" reading_order_no="3" segment_no="3" tag_type="title">Review<b>Cell Division</b></text>
<text top="105" left="55" width="476" height="15" font="font9" id="p1_t7" reading_order_no="4" segment_no="4" tag_type="title">The cyclin D1b splice variant: an old oncogene learns new tricks<a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="122" left="55" width="120" height="14" font="font10" id="p1_t8" reading_order_no="5" segment_no="5" tag_type="text">Karen E Knudsen*</text>
<text top="158" left="55" width="496" height="8" font="font11" id="p1_t9" reading_order_no="6" segment_no="6" tag_type="text">Address: Department of Cell Biology, Center for Environmental Genetics, and UC Cancer Center, University of Cincinnati College of Medicine,<b>The cyclin D1b splice variant: an old oncogene learns new tricks</b></text>
<text top="167" left="55" width="123" height="8" font="font11" id="p1_t10" reading_order_no="7" segment_no="6" tag_type="text">Cincinnati, Ohio 45267-0521, USA</text>
<text top="182" left="55" width="176" height="8" font="font11" id="p1_t11" reading_order_no="8" segment_no="7" tag_type="text">Email: Karen E Knudsen* - karen.knudsen@uc.edu</text>
<text top="193" left="55" width="92" height="8" font="font11" id="p1_t12" reading_order_no="9" segment_no="8" tag_type="text">* Corresponding author</text>
<text top="341" left="112" width="44" height="10" font="font12" id="p1_t13" reading_order_no="19" segment_no="16" tag_type="title">Abstract</text>
<text top="356" left="112" width="386" height="9" font="font13" id="p1_t14" reading_order_no="20" segment_no="17" tag_type="text">The function of cyclin D1 as a positive regulator of the cell cycle and proto-oncogene has been well<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=16863592">  </a></text>
<text top="368" left="112" width="386" height="9" font="font13" id="p1_t15" reading_order_no="21" segment_no="17" tag_type="text">established. Cyclin D1 elicits its pro-proliferative function early in G1 phase, through its ability to<b>Abstract</b></text>
<text top="380" left="112" width="386" height="9" font="font13" id="p1_t16" reading_order_no="22" segment_no="17" tag_type="text">activate cyclin dependent kinase (CDK) 4 or 6. Active CDK4/6-cyclin D1 complexes phosphorylate</text>
<text top="391" left="112" width="385" height="9" font="font13" id="p1_t17" reading_order_no="23" segment_no="17" tag_type="text">substrates that are critical for modulating G1 to S phase progression, and in this manner promote</text>
<text top="403" left="112" width="386" height="9" font="font13" id="p1_t18" reading_order_no="24" segment_no="17" tag_type="text">cellular proliferation. Emerging data from a number of model systems revealed that cyclin D1 also</text>
<text top="415" left="112" width="385" height="9" font="font13" id="p1_t19" reading_order_no="25" segment_no="17" tag_type="text">holds multiple, kinase-independent cellular functions. First, cyclin D1 assists in sequestering CDK</text>
<text top="426" left="112" width="385" height="10" font="font13" id="p1_t20" reading_order_no="26" segment_no="17" tag_type="text">inhibitors (e.g. p27 kip1 ), thus bolstering late G1 CDK activity. Second, cyclin D1 is known to bind</text>
<text top="438" left="112" width="386" height="9" font="font13" id="p1_t21" reading_order_no="27" segment_no="17" tag_type="text">and modulate the action of several transcription factors that hold significance in human cancers.</text>
<text top="450" left="112" width="386" height="9" font="font13" id="p1_t22" reading_order_no="28" segment_no="17" tag_type="text">Thus, cyclin D1 impinges on several distinct pathways that govern cancer cell proliferation.</text>
<text top="462" left="112" width="386" height="9" font="font13" id="p1_t23" reading_order_no="29" segment_no="17" tag_type="text">Although intragenic somatic mutation of cyclin D1 in human disease is rare, cyclin D1 gene</text>
<text top="474" left="112" width="385" height="9" font="font13" id="p1_t24" reading_order_no="30" segment_no="17" tag_type="text">translocation, amplification and/or overexpression are frequent events in selected tumor types.</text>
<text top="485" left="112" width="386" height="9" font="font13" id="p1_t25" reading_order_no="31" segment_no="17" tag_type="text">Additionally, a polymorphism in the cyclin D1 locus that may affect splicing has been implicated in</text>
<text top="497" left="112" width="386" height="9" font="font13" id="p1_t26" reading_order_no="32" segment_no="17" tag_type="text">increased cancer risk or poor outcome. Recent functional analyses of an established cyclin D1</text>
<text top="509" left="112" width="386" height="9" font="font13" id="p1_t27" reading_order_no="33" segment_no="17" tag_type="text">splice variant, cyclin D1b, revealed that the cyclin D1b isoform harbors unique activities in cancer</text>
<text top="521" left="112" width="386" height="9" font="font13" id="p1_t28" reading_order_no="34" segment_no="17" tag_type="text">cells. Here, we review the literature implicating cyclin D1b as a mediator of aberrant cellular</text>
<text top="532" left="112" width="386" height="9" font="font13" id="p1_t29" reading_order_no="35" segment_no="17" tag_type="text">proliferation in cancer. The differential roles of cyclin D1 and the cyclin D1b splice variant in</text>
<text top="544" left="112" width="386" height="9" font="font13" id="p1_t30" reading_order_no="36" segment_no="17" tag_type="text">prostate cancer will be also be addressed, wherein divergent functions have been linked to altered</text>
<text top="556" left="112" width="82" height="9" font="font13" id="p1_t31" reading_order_no="37" segment_no="17" tag_type="text">proliferative control.</text>
<text top="605" left="55" width="60" height="10" font="font12" id="p1_t32" reading_order_no="38" segment_no="18" tag_type="title">Background</text>
<text top="617" left="55" width="241" height="9" font="font15" id="p1_t33" reading_order_no="39" segment_no="20" tag_type="text">Cyclin D1 is a focal point for integrating mitogenic stim-</text>
<text top="629" left="55" width="241" height="9" font="font15" id="p1_t34" reading_order_no="40" segment_no="20" tag_type="text">ulation with cellular proliferation [1,2]. Mitogenic signals</text>
<text top="640" left="55" width="241" height="9" font="font15" id="p1_t35" reading_order_no="41" segment_no="20" tag_type="text">typically induce increases in cyclin D1 mRNA expression</text>
<text top="652" left="55" width="241" height="9" font="font15" id="p1_t36" reading_order_no="42" segment_no="20" tag_type="text">and translation, thereby increasing the cellular pool of the<b>Background</b></text>
<text top="664" left="55" width="241" height="9" font="font15" id="p1_t37" reading_order_no="43" segment_no="20" tag_type="text">protein product. The pro-proliferative function of cyclin</text>
<text top="676" left="55" width="241" height="9" font="font15" id="p1_t38" reading_order_no="44" segment_no="20" tag_type="text">D1 is mediated through its ability to regulate the cell cycle<a href="">n [1,2]. M</a>itogenic signals</text>
<text top="687" left="55" width="241" height="9" font="font15" id="p1_t39" reading_order_no="45" segment_no="20" tag_type="text">machinery, and excessive cyclin D1 expression and/or</text>
<text top="699" left="55" width="241" height="9" font="font15" id="p1_t40" reading_order_no="46" segment_no="20" tag_type="text">activity is a hallmark of several tumor types [3,4]. In addi-</text>
<text top="711" left="55" width="241" height="9" font="font15" id="p1_t41" reading_order_no="47" segment_no="20" tag_type="text">tion, cyclin D1 has cell cycle-independent functions</text>
<text top="722" left="55" width="241" height="9" font="font15" id="p1_t42" reading_order_no="48" segment_no="20" tag_type="text">through its ability to modulate transcription factor action</text>
<text top="605" left="313" width="241" height="9" font="font15" id="p1_t43" reading_order_no="49" segment_no="19" tag_type="text">[5]. Given the importance of cyclin D1 in human disease,</text>
<text top="617" left="313" width="241" height="9" font="font15" id="p1_t44" reading_order_no="50" segment_no="19" tag_type="text">concerted effort has been directed at delineating the<a href="">s [3,4]. </a>In addi-</text>
<text top="629" left="313" width="241" height="9" font="font15" id="p1_t45" reading_order_no="51" segment_no="19" tag_type="text">mechanisms by which cyclin D1 is dysregulated in cancer.</text>
<text top="640" left="313" width="241" height="9" font="font15" id="p1_t46" reading_order_no="52" segment_no="19" tag_type="text">In selected tumor types, cyclin D1 is overexpressed as a</text>
<text top="652" left="313" width="241" height="9" font="font15" id="p1_t47" reading_order_no="53" segment_no="19" tag_type="text">result of chromosomal translocation or amplification of<a href="">[5]. Given the impo</a>rtance of cyclin D1 in human disease,</text>
<text top="664" left="313" width="241" height="9" font="font15" id="p1_t48" reading_order_no="54" segment_no="19" tag_type="text">the cyclin D1 (CCND1, PRAD) locus [1,6]. Intragenic</text>
<text top="676" left="313" width="241" height="9" font="font15" id="p1_t49" reading_order_no="55" segment_no="19" tag_type="text">somatic mutations of cyclin D1 are rare, but a polymor-</text>
<text top="687" left="313" width="241" height="9" font="font15" id="p1_t50" reading_order_no="56" segment_no="19" tag_type="text">phism of cyclin D1 that occurs in a splice donor site has</text>
<text top="699" left="313" width="241" height="9" font="font15" id="p1_t51" reading_order_no="57" segment_no="19" tag_type="text">been epidemiologically linked to increased cancer risk or</text>
<text top="711" left="313" width="241" height="9" font="font15" id="p1_t52" reading_order_no="58" segment_no="19" tag_type="text">poor prognosis in a number of tumor types (reviewed in<a href="">s [1,6]</a>. Intragenic</text>
<text top="722" left="313" width="241" height="9" font="font15" id="p1_t53" reading_order_no="59" segment_no="19" tag_type="text">[7]). Recent functional analyses have revealed that the</text>
<text top="236" left="55" width="74" height="7" font="font16" id="p1_t54" reading_order_no="10" segment_no="9" tag_type="text">Published: 24 July 2006</text>
<text top="250" left="55" width="73" height="7" font="font17" id="p1_t55" reading_order_no="11" segment_no="12" tag_type="text">Cell Division 2006, 1 :15</text>
<text top="250" left="136" width="92" height="7" font="font16" id="p1_t56" reading_order_no="12" segment_no="12" tag_type="text">doi:10.1186/1747-1028-1-15</text>
<text top="236" left="310" width="75" height="7" font="font16" id="p1_t57" reading_order_no="17" segment_no="10" tag_type="text">Received: 19 June 2006<a href="">[7]). </a>Recent functional analyses have revealed that the</text>
<text top="245" left="310" width="74" height="7" font="font16" id="p1_t58" reading_order_no="18" segment_no="11" tag_type="text">Accepted: 24 July 2006</text>
<text top="264" left="55" width="219" height="7" font="font16" id="p1_t59" reading_order_no="13" segment_no="13" tag_type="text">This article is available from: http://www.celldiv.com/content/1/1/15<i>Cell Division</i></text>
<text top="279" left="55" width="153" height="7" font="font16" id="p1_t60" reading_order_no="14" segment_no="14" tag_type="text">Â© 2006 Knudsen; licensee BioMed Central Ltd.</text>
<text top="288" left="55" width="492" height="7" font="font16" id="p1_t61" reading_order_no="15" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),<b>1</b></text>
<text top="297" left="55" width="400" height="7" font="font16" id="p1_t62" reading_order_no="16" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
